Health

News Hour: Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49. The vaccine, which is already approved for...

News Hour: An Austrian biotech company working with the Institut Pasteur said on Tuesday it planned to start clinical trials with an experimental Zika vaccine in the next 12 months, marking a further acceleration of research...

News Hour: Juno Therapeutics Inc  said U.S. health regulators have removed a clinical hold on its cancer drug trial that was put in place last week following the death of three patients, sending its shares up about...

News Hour: Amgen Inc’s cheaper version of AbbVie’s top-selling arthritis drug Humira is highly similar to the original and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The...

News Hour: The South Africa that hosts a global AIDS Conference next week has come a long way from the “AIDS pariah” that did so 16 years ago, when then President Thabo Mbeki stunningly dismissed the...

News Hour: British drugmaker AstraZeneca Plc said on Wednesday it has entered into an agreement with Sandoz, the generic pharmaceuticals division of Novartis AG, to resolve Faslodex patent litigation in the U.S. The company said it...

News Hour: The Japan Voluntary Organizations Active in Disaster (JVOAD) Preparatory Committee (Representative: Nobuyuki Kurita) held a founding meeting of the JVOAD on June 7, 2016, in aiming to incorporate as a specified non-profit organization. Takeda...

News Hour: Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine  announced that they will expand the focus of the successful Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a partnership established in 2013...

News Hour: Takeda Pharmaceutical Company Limited  and M2Gen®, a healthcare informatics solutions company, have established a new collaboration to generate broad genomic data from consenting cancer patients. Under the agreement, Takeda will help build the Oncology...

News Hour: Takeda Pharmaceutical Company Limited  announced the decision for three projects to be subsidized in the second year (October 2015 to September 2016) of the Civil Society Initiative Subsidy Program « Takeda Well-Being Program II : Giving...